XML 35 R16.htm IDEA: XBRL DOCUMENT v3.25.1
Note 8 - Warrants
12 Months Ended
Dec. 31, 2024
Notes to Financial Statements  
Class of Warrant or Right [Text Block]

8.

WARRANTS  

 

The changes in warrants are as follows:

 

  

Number of

warrants

  

Weighted

average exercise

price

(CAD)

  

Aggregate

Intrinsic Value

 
             

Warrants outstanding, December 31, 2022

  17,400,000  $0.28  $- 

Expired

  (4,900,000)  (1.00)  - 

Warrants outstanding, December 31, 2023 and 2024

  12,500,000  $0.001  $- 

 

Details of warrants outstanding as at December 31, 2024 are as follows:

 

Exercise price

   

Number of

warrants

outstanding

 

Expiry date

 

Number of

warrants

exercisable

  

Remaining

contractual life

(years)

 
                 
$0.001 

(1) (USA)

  12,500,000 

June 4, 2025

  -   0.43 
                 
      12,500,000    -     

 

 

(1)

No share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being 1) targeted revenue sales projections met, or 2) listing on a major US exchange, or 3) change of control.